Aarti Drugs Limited — Call Transcript 2023

Oct 16, 2023

==> picture [512 x 106] intentionally omitted <==

Ref: ADL/SE/2023-24/78 October 16, 2023

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051

BSE CODE – 524348

NSE SYMBOL: AARTIDRUGS

Dear Sir/Madam,

Ref : Regulation 30 of SEBI (LODR) Regulations, 2015 Sub: Intimation of Earning Conference Call

This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts has been scheduled on Friday, October 20, 2023 at 11:00 A.M. IST to discuss the Company’s financial performance for the Quarter ended September 30, 2023. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, RUSHIKESH pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f6 35abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b5 VIVEK DEOLE 75f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2023.10.16 17:10:28 +05'30'

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 29] intentionally omitted <==

==> picture [287 x 50] intentionally omitted <==

Aarti Drugs Limited Q2 & H1 FY24 Earnings Conference Call

DATE & TIME 20[th] October 2023 (Friday) 11:00 am, IST (HK/Singapore 1:30 pm, UK 6:30 am, USA 1:30 am EST)

PARTICIPANTS

– Mr. Harshit Savla Jt. Managing Director Mr. Harit Shah – Whole time Director Mr. Adhish Patil – Chief Finance Officer

PRE REGISTRATION LINK – CLICK HERE

CONFERENCE DIAL IN DETAILS

INDIA +91 22 6280 1309 / +91 22 7115 8210 UNITED STATES 1 866 746 2133 UNITED KINGDOM 0 808 101 1573 SINGAPORE 800 101 2045 HONG KONG 800 964 448

RSVP:

Strategic Growth Advisors Pvt. Ltd. Mr. Deven Dhruva / Mr. Harsh Shah Contact: +91 98333 73300 / +91 97689 74808